Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2025-12-25 @ 5:15 PM
NCT ID:
NCT02775903
Group ID:
EG002
Title:
AML: Azacitidine + Durvalumab
Description:
Participants with AML received 75 mg/m² subcutaneous azacitidine for 7 days every 4 weeks (Q4W) in combination with 1500 mg intravenous durvalumab on Day 1 of every 4 week cycle for at least 6 cycles. Participants who benefited from treatment may have continued treatment until loss of that benefit, disease progression or other treatment discontinuation criterion were met.
Deaths Number Affected:
48
Deaths Number At Risk:
None
Serious Number Affected:
56
Serious Number At Risk:
64
Other Number Affected:
63
Other Number At Risk:
64
Study:
NCT02775903
Results Section:
NCT02775903
Adverse Events Module:
NCT02775903